ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,690.67
1.27%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Solid Biosciences Inc (SLDB)

  7. Solid Biosciences Inc (SLDB) Noticias

SLDB Solid Biosciences Inc

10.10
-0.13 (-1.27%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Solid Biosciences Inc SLDB NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.13 -1.27% 10.10 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
10.33 10.02 10.70 10.10 10.23
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202415:05GLOBESolid Biosciences Reports Inducement Grants Under Nasdaq..
03/4/202415:05GLOBESolid Biosciences Reports Inducement Grants Under Nasdaq..
01/4/202406:45GLOBESolid Biosciences Receives Rare Pediatric Disease..
27/3/202406:00GLOBESolid Biosciences to Participate at Cantor’s Virtual..
13/3/202406:44GLOBESolid Biosciences Provides Fourth Quarter and Full-Year 2023..
07/3/202406:00GLOBESolid Biosciences Announces Licensing Agreement with Armatus..
06/3/202407:00GLOBESolid Biosciences to Participate at Upcoming Investor..
16/2/202411:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202410:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202410:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202410:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202410:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202409:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
30/1/202416:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202415:09EDGAR2Form S-3 - Registration statement under Securities Act of..
16/1/202407:50DJNSolid Biosciences Gets Orphan Drug Designation for SGT-003
16/1/202407:00GLOBESolid Biosciences Granted FDA Orphan Drug Designation for..
12/1/202416:05EDGAR2Form SC 13D/A - General statement of acquisition of..
11/1/202416:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202415:31EDGAR2Form SC 13D/A - General statement of acquisition of..
08/1/202406:24EDGAR2Form 8-K - Current report
08/1/202406:09GLOBESolid Biosciences Announces $109 Million Private Placement
05/1/202418:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202407:00GLOBESolid Biosciences to Participate at 42nd Annual J.P. Morgan..
07/12/202309:49DJNSolid Biosciences Shares Jump After FDA Fast-Tracks SGT-0003
07/12/202307:00GLOBESolid Biosciences Receives FDA Fast Track Designation for..
05/12/202313:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202313:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202313:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202313:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202307:00GLOBESolid Biosciences to Participate at 35th Annual Piper..
15/11/202307:51IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Analyst..
15/11/202306:59EDGAR2Form 8-K - Current report
14/11/202315:05GLOBESolid Biosciences Announces IND Clearance by FDA for..
09/11/202307:00GLOBESolid Biosciences to Participate at Jefferies London..
08/11/202315:17GLOBESolid Biosciences Provides Third Quarter Business Update and..
08/11/202315:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
20/10/202315:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202315:17EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/10/202307:00GLOBESolid Biosciences Appoints Gabriel Brooks, M.D., as Chief..
20/9/202307:00GLOBESolid Biosciences to Participate at Upcoming Investor..
06/9/202315:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202307:56GLOBESolid Biosciences to Participate at Upcoming Investor..
31/8/202307:00GLOBESolid Biosciences to Participate in Citi’s 18th Annual..
14/8/202315:17GLOBESolid Biosciences Provides Second Quarter Business Update..
14/8/202315:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/6/202307:00GLOBESolid Biosciences to Participate at the Jefferies Healthcare..
22/5/202307:00GLOBESolid Biosciences to Participate at the Barclays Gene..
16/5/202307:00GLOBESolid Biosciences to Present at the American Society of Gene..

Su Consulta Reciente

NASDAQ
SLDB
Solid Biosciences
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados